Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice

ConclusionThe antiatherosclerotic effect of BBR is related to alterations in gut microbiota compositions, indicating the potential therapeutic value of pharmacological approaches that may modulate the gut microbiota in treating atherosclerosis.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research